Volume 14, Issue 9, Pages (March 2016)

Slides:



Advertisements
Similar presentations
Volume 94, Issue 2, Pages (March 2014)
Advertisements

Figure 1. CD11b+CD33+CD14+HLA-DR−/lo myeloid-derived suppressor cell expansion by human immunodeficiency virus.
PBMCs from patients with chronic myeloid leukemia treated with different tyrosine kinase inhibitors show variable susceptibility to HIV-1 infection: searching.
Volume 36, Issue 3, Pages (March 2012)
CD4+CD25+ Immunoregulatory T Cells
Molecular Therapy - Methods & Clinical Development
Volume 9, Issue 5, Pages (November 1998)
Cord Blood–Derived and Peripheral Blood–Derived Cytokine-Induced Killer Cells Are Sensitive to Fas-Mediated Apoptosis  Ludovic Durrieu, Mame Massar Dieng,
Volume 21, Issue 9, Pages (November 2017)
Sequential Polarization and Imprinting of Type 1 T Helper Lymphocytes by Interferon-γ and Interleukin-12  Edda G. Schulz, Luca Mariani, Andreas Radbruch,
Volume 21, Issue 12, Pages (December 2017)
Volume 13, Issue 6, Pages (November 2015)
Skin-Resident Effector Memory CD8+CD28– T Cells Exhibit a Profibrotic Phenotype in Patients with Systemic Sclerosis  Gang Li, Adriana T. Larregina, Robyn.
Helium–Neon Laser Irradiation Stimulates Cell Proliferation through Photostimulatory Effects in Mitochondria  Wan-Ping Hu, Jeh-Jeng Wang, Chia-Li Yu,
FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides.
IL-13-Stimulated Human Keratinocytes Preferentially Attract CD4+CCR4+ T cells: Possible Role in Atopic Dermatitis  Rahul Purwar, Thomas Werfel, Miriam.
Volume 18, Issue 1, Pages (January 2017)
Volume 20, Issue 12, Pages (September 2017)
Volume 13, Issue 5, Pages (May 2013)
Volume 22, Issue 3, Pages (January 2018)
Volume 21, Issue 11, Pages (December 2017)
Volume 21, Issue 1, Pages (October 2017)
Volume 34, Issue 1, Pages (January 2011)
Volume 24, Issue 8, Pages (August 2018)
Volume 3, Issue 4, Pages (April 2013)
Volume 15, Issue 4, Pages (October 2001)
Volume 18, Issue 5, Pages (January 2017)
Volume 29, Issue 4, Pages (October 2008)
Volume 16, Issue 11, Pages (September 2016)
Volume 39, Issue 1, Pages (July 2013)
Volume 135, Issue 1, Pages (July 2008)
Xiaolong Wei, Hai Xu, Donald Kufe  Cancer Cell 
Volume 18, Issue 13, Pages (March 2017)
Leslie van der Fits, Jacoba J. Out-Luiting, Cornelis P
Molecular Therapy - Nucleic Acids
Reactivation of Latent HIV-1 by Inhibition of BRD4
Volume 17, Issue 9, Pages (November 2016)
Volume 22, Issue 9, Pages (February 2018)
Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
Volume 48, Issue 4, Pages e4 (April 2018)
Volume 17, Issue 1, Pages (January 2015)
Volume 16, Issue 2, Pages (July 2016)
Anti-Mycotics Suppress Interleukin-4 and Interleukin-5 Production in Anti-CD3 Plus Anti- CD28-Stimulated T Cells from Patients with Atopic Dermatitis 
Volume 32, Issue 1, Pages (January 2010)
Volume 17, Issue 2, Pages (October 2016)
Volume 96, Issue 6, Pages (March 1999)
Volume 36, Issue 3, Pages (March 2012)
Nathalie Schmitt, Yang Liu, Salah-Eddine Bentebibel, Hideki Ueno 
Cellular 5′-3′ mRNA Exonuclease Xrn1 Controls Double-Stranded RNA Accumulation and Anti-Viral Responses  Hannah M. Burgess, Ian Mohr  Cell Host & Microbe 
Volume 39, Issue 6, Pages (December 2013)
17β-Estradiol Inhibits Oxidative Stress-Induced Apoptosis in Keratinocytes by Promoting Bcl-2 Expression  Naoko Kanda, Shinichi Watanabe  Journal of Investigative.
Volume 20, Issue 12, Pages (September 2017)
Volume 47, Issue 4, Pages e3 (October 2017)
Volume 17, Issue 5, Pages (October 2016)
Harald Renz, MD, Chaya Brodie, PhD, Katherine Bradley, BS, Donald Y. M
Duy Pham, PhD, Sarita Sehra, PhD, Xin Sun, PhD, Mark H. Kaplan, PhD 
Volume 15, Issue 4, Pages (October 2001)
Molecular Therapy - Oncolytics
Volume 26, Issue 13, Pages e6 (March 2019)
Volume 31, Issue 6, Pages (December 2009)
Members of IL-1 family of cytokines favor the generation of IL-3–secreting CD4+ T cells in vitro. Members of IL-1 family of cytokines favor the generation.
Volume 26, Issue 3, Pages e3 (January 2019)
Volume 27, Issue 1, Pages e4 (April 2019)
Zinc-Finger Nucleases Induced by HIV-1 Tat Excise HIV-1 from the Host Genome in Infected and Latently Infected Cells  Haiyan Ji, Panpan Lu, Baochi Liu,
Volume 7, Issue 2, Pages (April 2014)
Volume 19, Issue 5, Pages (May 2017)
Molecular Therapy - Nucleic Acids
Volume 15, Issue 4, Pages (April 2016)
Volume 18, Issue 5, Pages (January 2017)
Volume 17, Issue 5, Pages (October 2016)
Presentation transcript:

Volume 14, Issue 9, Pages 2100-2107 (March 2016) IL-7 Induces SAMHD1 Phosphorylation in CD4+ T Lymphocytes, Improving Early Steps of HIV-1 Life Cycle  Mayte Coiras, Mercedes Bermejo, Benjamin Descours, Elena Mateos, Javier García-Pérez, María-Rosa López-Huertas, Michael M. Lederman, Monsef Benkirane, José Alcamí  Cell Reports  Volume 14, Issue 9, Pages 2100-2107 (March 2016) DOI: 10.1016/j.celrep.2016.02.022 Copyright © 2016 The Authors Terms and Conditions

Cell Reports 2016 14, 2100-2107DOI: (10.1016/j.celrep.2016.02.022) Copyright © 2016 The Authors Terms and Conditions

Figure 1 Kinetics of SAMHD1 Phosphorylation at T592 in Primary CD4+ Lymphocytes in Response to Different Stimuli (A) Whole protein extracts from CD4+ T cells treated with anti-CD3/CD28 for 5 consecutive days in the presence or not of IL-2 were analyzed by immunoblotting using a specific antibody against total and phosphorylated (T592) SAMHD1. (B) Phosphorylation of SAMHD1 was analyzed by immunoblotting in whole protein extracts from CD4+ T cells treated with IL-2 or IL-7 for 5 consecutive days. (C) Analysis by immunoblotting of the effect on SAMHD1 phosphorylation of IL-2 or IL-7 depletion for 48 hr in CD4+ lymphocytes that were previously treated for 5 days. (D) Analysis of SAMHD1 phosphorylation by immunoblotting in CD4+ lymphocytes treated with chemokines CXCL12 or CXCL9/10 for 5 days, as well as with IL-2 or IL-7. Cell Reports 2016 14, 2100-2107DOI: (10.1016/j.celrep.2016.02.022) Copyright © 2016 The Authors Terms and Conditions

Figure 2 Effect of IL-2 and IL-7 on Reverse Transcription and Proviral Integration in HIV-Infected Primary CD4+ Lymphocytes (A) Analysis by qPCR of the reverse transcription of NL4-3_luciferase strain in CD4+ lymphocytes treated with IL-2 and IL-7 for 5 days and then infected for 5 hr. (B and C) The same cells were further cultured for 5 days and then 2-LTRs circles (B) and proviral integration (C) were quantified by qPCR. (D) Analysis by qPCR of proviral integration in CD4+ lymphocytes treated with IL-2 or IL-7 for 5 days and then infected with NL4-3_Renilla luciferase infectious strain and incubated for 5 days more in the presence or not of CXCL9 and CXCL10. (E) Purified CD4+ T cells were transfected in resting conditions with pOZ-SAMHD1_WT or pOZ-SAMHD1_T592A and then treated with IL-2 or IL-7 for 4 days. Cells were then infected with NL4-3_Renilla and incubated for 48 hr before measuring the synthesis of Renilla (RLUs). One representative experiment is shown. Statistical significance was calculated using two-way ANOVA for (A), one-way ANOVA for (B) and (C), and Mann-Whitney t test for (D). ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. All data are represented as mean ± the SEM. Cell Reports 2016 14, 2100-2107DOI: (10.1016/j.celrep.2016.02.022) Copyright © 2016 The Authors Terms and Conditions

Figure 3 IL-7 Induced Mostly Latent Proviral Integration (A) Measurement of luciferase production (RLUs) in primary CD4+ T cells treated with IL-2 and IL-7 for 5 days and then infected with NL4-3_Renilla luciferase for 5 days more. PMA was added during the last 18 hr. SAMHD1 levels were analyzed by immunoblotting as described in Figure 1. (B) Analysis of luciferase expression in resting CD4+ T cells treated with IL-2 or IL-7 for 5 days and then nucleofected with pLTR-LUC or pκB-LUC vectors. PMA was added 2 hr post-transfection, and cells were incubated for subsequent 18 hr. Statistical significance was calculated using two-way ANOVA. ∗∗∗p < 0.001. Data are represented as mean ± SEM. Cell Reports 2016 14, 2100-2107DOI: (10.1016/j.celrep.2016.02.022) Copyright © 2016 The Authors Terms and Conditions

Figure 4 SAMHD1 Phosphorylation in Different CD4+ T Cell Subsets from HIV-1-Infected Patients Included in the ACTG 5214 Study Who Received a Single Dose of IL-7 Surface staining with antibodies against CCR7 and CD45RA allowed distributing cells in the different CD4+ T cell subsets (depicted in the upper drawing). Subsequent intracellular staining was performed with an antibody against SAMHD1 phosphorylated at T592. Before-after graphs were depicted for each CD4+ T cell subset. Statistical significance was calculated using Mann-Whitney t test. ∗p < 0.05; “ns” for not significant. Data are represented as mean ± SEM. The mean percentages and SEM for SAMHD1 phosphorylation at day 0 and day 4 are shown in the lower table. Cell Reports 2016 14, 2100-2107DOI: (10.1016/j.celrep.2016.02.022) Copyright © 2016 The Authors Terms and Conditions

Figure 5 Cytostatic Drug Dasatinib Interfered with IL-7-Induced SAMHD1 Phosphorylation (A) Analysis by immunoblotting of SAMHD1 phosphorylation in CD4+ T cells isolated from healthy donors that were treated with IL-7 for 5 days in the presence of dasatinib. (B and C) Viral reverse transcription (B) and proviral integration (C) were analyzed by qPCR in CD4+ T cells treated with IL-7 for 5 days in the presence or not of dasatinib and infected with NL4-3_Renilla luciferase strain for subsequent 5 days. (D) Luciferase activity was measured in cell extracts 48 hr after infection. Statistical significance was calculated using two-way ANOVA for (B) and Mann-Whitney t test for (C). ∗p < 0.05. Data are represented as mean ± SEM. Cell Reports 2016 14, 2100-2107DOI: (10.1016/j.celrep.2016.02.022) Copyright © 2016 The Authors Terms and Conditions